TAVI for patients with normal-flow low-gradient compared to high-gradient aortic stenosis

Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gr...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cardiology Vol. 371; pp. 299 - 304
Main Authors Steffen, Julius, Andreae, David, Nabauer, Michael, Reißig, Nikolas, Doldi, Philipp M., Haum, Magda, Orban, Martin, Theiss, Hans, Rizas, Konstantinos, Braun, Daniel, Peterß, Sven, Hausleiter, Jörg, Massberg, Steffen, Deseive, Simon
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 15.01.2023
Subjects
Online AccessGet full text
ISSN0167-5273
1874-1754
1874-1754
DOI10.1016/j.ijcard.2022.10.143

Cover

Loading…
Abstract Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gradient aortic stenosis patients (dPmean ≥40 mmHg, HG-AS) concerning characteristics and outcomes. 2326 patients undergoing transcatheter aortic valve replacement (TAVI) at our centre between 2013 and 2019 were analysed. 386 patients fulfilled criteria of NFLG-AS. Their median dPmean was 33 mmHg, which was used for grouping (204 patients with higher gradient NFLG-AS, 186 patients with lower gradient NFLG-AS). They were compared to 956 HG-AS patients. Characteristics of lower gradient NFLG-AS patients differed from HG-AS patients in many aspects while higher gradient NFLG-AS and HG-AS patients were mostly similar, underscored by higher Society of Thoracic Surgeons scores in lower gradient NFLG-AS (lower gradient NFLG-AS, 3.9, HG-AS, 3.0, p = 0.03, higher gradient NFLG-AS, 3.0, p = 0.04). Procedural complications were comparable. Estimated 3-year all-cause mortality was higher in lower gradient NFLG-AS compared to HG-AS patients (hazard ratio 1.7, p < 0.01), whereas mortality of higher gradient NFLG-AS was similar to HG-AS patients (hazard ratio 1.2, p = 0.31). Cardiovascular mortality was highest among lower gradient NFLG-AS patients (21.6% vs. higher gradient NFLG-AS, 15.4%, vs. HG-AS, 11.1%, p < 0.01). NFLG-AS patients are indeed heterogenous. NFLG-AS patients with higher gradients resemble HG-AS patients in clinical characteristics and outcomes and should not be treated differently. Lower gradient NFLG-AS patients have increased long-term mortality and the use of TAVI requires careful consideration. •Normal-flow low-gradient aortic stenosis (NFLG-AS) is a common subset.•Guidelines give no conclusive recommendations for patients with NFLG-AS.•Patients with NFLG-AS are a heterogeneous cohort; dPmean can discriminate subsets.•NFLG-AS patients with higher dPmean resemble high-gradient AS patients.•NFLG-AS patients with lower dPmean have an increased mortality after TAVI.
AbstractList Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gradient aortic stenosis patients (dPmean ≥40 mmHg, HG-AS) concerning characteristics and outcomes.BACKGROUNDNormal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gradient aortic stenosis patients (dPmean ≥40 mmHg, HG-AS) concerning characteristics and outcomes.2326 patients undergoing transcatheter aortic valve replacement (TAVI) at our centre between 2013 and 2019 were analysed. 386 patients fulfilled criteria of NFLG-AS. Their median dPmean was 33 mmHg, which was used for grouping (204 patients with higher gradient NFLG-AS, 186 patients with lower gradient NFLG-AS). They were compared to 956 HG-AS patients.METHODS2326 patients undergoing transcatheter aortic valve replacement (TAVI) at our centre between 2013 and 2019 were analysed. 386 patients fulfilled criteria of NFLG-AS. Their median dPmean was 33 mmHg, which was used for grouping (204 patients with higher gradient NFLG-AS, 186 patients with lower gradient NFLG-AS). They were compared to 956 HG-AS patients.Characteristics of lower gradient NFLG-AS patients differed from HG-AS patients in many aspects while higher gradient NFLG-AS and HG-AS patients were mostly similar, underscored by higher Society of Thoracic Surgeons scores in lower gradient NFLG-AS (lower gradient NFLG-AS, 3.9, HG-AS, 3.0, p = 0.03, higher gradient NFLG-AS, 3.0, p = 0.04). Procedural complications were comparable. Estimated 3-year all-cause mortality was higher in lower gradient NFLG-AS compared to HG-AS patients (hazard ratio 1.7, p < 0.01), whereas mortality of higher gradient NFLG-AS was similar to HG-AS patients (hazard ratio 1.2, p = 0.31). Cardiovascular mortality was highest among lower gradient NFLG-AS patients (21.6% vs. higher gradient NFLG-AS, 15.4%, vs. HG-AS, 11.1%, p < 0.01).RESULTSCharacteristics of lower gradient NFLG-AS patients differed from HG-AS patients in many aspects while higher gradient NFLG-AS and HG-AS patients were mostly similar, underscored by higher Society of Thoracic Surgeons scores in lower gradient NFLG-AS (lower gradient NFLG-AS, 3.9, HG-AS, 3.0, p = 0.03, higher gradient NFLG-AS, 3.0, p = 0.04). Procedural complications were comparable. Estimated 3-year all-cause mortality was higher in lower gradient NFLG-AS compared to HG-AS patients (hazard ratio 1.7, p < 0.01), whereas mortality of higher gradient NFLG-AS was similar to HG-AS patients (hazard ratio 1.2, p = 0.31). Cardiovascular mortality was highest among lower gradient NFLG-AS patients (21.6% vs. higher gradient NFLG-AS, 15.4%, vs. HG-AS, 11.1%, p < 0.01).NFLG-AS patients are indeed heterogenous. NFLG-AS patients with higher gradients resemble HG-AS patients in clinical characteristics and outcomes and should not be treated differently. Lower gradient NFLG-AS patients have increased long-term mortality and the use of TAVI requires careful consideration.CONCLUSIONSNFLG-AS patients are indeed heterogenous. NFLG-AS patients with higher gradients resemble HG-AS patients in clinical characteristics and outcomes and should not be treated differently. Lower gradient NFLG-AS patients have increased long-term mortality and the use of TAVI requires careful consideration.
Normal-flow (stroke volume index, SVi >35 ml/m ) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gradient aortic stenosis patients (dPmean ≥40 mmHg, HG-AS) concerning characteristics and outcomes. 2326 patients undergoing transcatheter aortic valve replacement (TAVI) at our centre between 2013 and 2019 were analysed. 386 patients fulfilled criteria of NFLG-AS. Their median dPmean was 33 mmHg, which was used for grouping (204 patients with higher gradient NFLG-AS, 186 patients with lower gradient NFLG-AS). They were compared to 956 HG-AS patients. Characteristics of lower gradient NFLG-AS patients differed from HG-AS patients in many aspects while higher gradient NFLG-AS and HG-AS patients were mostly similar, underscored by higher Society of Thoracic Surgeons scores in lower gradient NFLG-AS (lower gradient NFLG-AS, 3.9, HG-AS, 3.0, p = 0.03, higher gradient NFLG-AS, 3.0, p = 0.04). Procedural complications were comparable. Estimated 3-year all-cause mortality was higher in lower gradient NFLG-AS compared to HG-AS patients (hazard ratio 1.7, p < 0.01), whereas mortality of higher gradient NFLG-AS was similar to HG-AS patients (hazard ratio 1.2, p = 0.31). Cardiovascular mortality was highest among lower gradient NFLG-AS patients (21.6% vs. higher gradient NFLG-AS, 15.4%, vs. HG-AS, 11.1%, p < 0.01). NFLG-AS patients are indeed heterogenous. NFLG-AS patients with higher gradients resemble HG-AS patients in clinical characteristics and outcomes and should not be treated differently. Lower gradient NFLG-AS patients have increased long-term mortality and the use of TAVI requires careful consideration.
Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gradient aortic stenosis patients (dPmean ≥40 mmHg, HG-AS) concerning characteristics and outcomes. 2326 patients undergoing transcatheter aortic valve replacement (TAVI) at our centre between 2013 and 2019 were analysed. 386 patients fulfilled criteria of NFLG-AS. Their median dPmean was 33 mmHg, which was used for grouping (204 patients with higher gradient NFLG-AS, 186 patients with lower gradient NFLG-AS). They were compared to 956 HG-AS patients. Characteristics of lower gradient NFLG-AS patients differed from HG-AS patients in many aspects while higher gradient NFLG-AS and HG-AS patients were mostly similar, underscored by higher Society of Thoracic Surgeons scores in lower gradient NFLG-AS (lower gradient NFLG-AS, 3.9, HG-AS, 3.0, p = 0.03, higher gradient NFLG-AS, 3.0, p = 0.04). Procedural complications were comparable. Estimated 3-year all-cause mortality was higher in lower gradient NFLG-AS compared to HG-AS patients (hazard ratio 1.7, p < 0.01), whereas mortality of higher gradient NFLG-AS was similar to HG-AS patients (hazard ratio 1.2, p = 0.31). Cardiovascular mortality was highest among lower gradient NFLG-AS patients (21.6% vs. higher gradient NFLG-AS, 15.4%, vs. HG-AS, 11.1%, p < 0.01). NFLG-AS patients are indeed heterogenous. NFLG-AS patients with higher gradients resemble HG-AS patients in clinical characteristics and outcomes and should not be treated differently. Lower gradient NFLG-AS patients have increased long-term mortality and the use of TAVI requires careful consideration. •Normal-flow low-gradient aortic stenosis (NFLG-AS) is a common subset.•Guidelines give no conclusive recommendations for patients with NFLG-AS.•Patients with NFLG-AS are a heterogeneous cohort; dPmean can discriminate subsets.•NFLG-AS patients with higher dPmean resemble high-gradient AS patients.•NFLG-AS patients with lower dPmean have an increased mortality after TAVI.
Author Andreae, David
Orban, Martin
Steffen, Julius
Theiss, Hans
Deseive, Simon
Peterß, Sven
Haum, Magda
Rizas, Konstantinos
Braun, Daniel
Reißig, Nikolas
Hausleiter, Jörg
Doldi, Philipp M.
Nabauer, Michael
Massberg, Steffen
Author_xml – sequence: 1
  givenname: Julius
  surname: Steffen
  fullname: Steffen, Julius
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 2
  givenname: David
  surname: Andreae
  fullname: Andreae, David
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 3
  givenname: Michael
  surname: Nabauer
  fullname: Nabauer, Michael
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 4
  givenname: Nikolas
  surname: Reißig
  fullname: Reißig, Nikolas
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 5
  givenname: Philipp M.
  surname: Doldi
  fullname: Doldi, Philipp M.
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 6
  givenname: Magda
  surname: Haum
  fullname: Haum, Magda
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 7
  givenname: Martin
  surname: Orban
  fullname: Orban, Martin
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 8
  givenname: Hans
  surname: Theiss
  fullname: Theiss, Hans
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 9
  givenname: Konstantinos
  surname: Rizas
  fullname: Rizas, Konstantinos
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 10
  givenname: Daniel
  surname: Braun
  fullname: Braun, Daniel
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 11
  givenname: Sven
  surname: Peterß
  fullname: Peterß, Sven
  organization: Herzchirurgische Klinik und Poliklinik, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 12
  givenname: Jörg
  surname: Hausleiter
  fullname: Hausleiter, Jörg
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 13
  givenname: Steffen
  surname: Massberg
  fullname: Massberg, Steffen
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
– sequence: 14
  givenname: Simon
  surname: Deseive
  fullname: Deseive, Simon
  email: simon.deseive@med.uni-muenchen.de
  organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36306951$$D View this record in MEDLINE/PubMed
BookMark eNqFkMtKAzEUhoMoWi9vIJKlm6nJ5NKOiFDES6HgRgVXIU3O2NSZSU1Sxbc3tYrgposQOOf7fzjfPtrufAcIHVPSp4TKs3nfzY0Otl-SsuyvppxtoR4dDnhBB4Jvo17GBoUoB2wP7cc4J4Twqhruoj0mGZGVoD30_DB6GuPaB7zQyUGXIv5waYY7H1rdFHXjP3B-xUvQdrXGxrcLHcDi5PHMvcz-NtqH5AyOCTofXTxEO7VuIhz9_Afo8eb64equmNzfjq9Gk8IwLlKhuZAlmFJrPpWWVawmltNSSAKUSDul9bBmdcWH0gKVlBBJBUgtBJXMAtPsAJ2uexfBvy0hJtW6aKBpdAd-GVU-n7AMizKjJz_octqCVYvgWh0-1a-ODJyvARN8jAFqZVzKXnyXgnaNokSt3Ku5WrtXK_ffU85ymP8L__ZviF2uY5AlvTsIKprs04B1AUxS1rtNBRf_CkzjOmd08wqfm-NfCVezlA
CitedBy_id crossref_primary_10_1007_s00392_023_02245_w
crossref_primary_10_1016_j_carrev_2024_06_014
Cites_doi 10.1093/ehjci/jez191
10.1038/bmt.2009.359
10.1093/eurheartj/ehw096
10.1016/j.jacc.2013.08.1621
10.1093/eurheartj/eht094
10.1016/j.jcin.2019.01.233
10.1161/CIRCULATIONAHA.112.001094
10.1007/s00392-022-02011-4
10.1093/eurheartj/ehaa799
10.1093/eurheartj/ehab395
10.1093/ehjci/jew335
10.1016/j.jcmg.2015.09.026
10.1161/JAHA.119.012301
10.1016/j.jacc.2020.02.046
10.1093/ehjci/jez211
10.1136/hrt.2003.030601
10.1161/CIRCULATIONAHA.112.001290
ContentType Journal Article
Copyright 2022 Elsevier B.V.
Copyright © 2022 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2022 Elsevier B.V.
– notice: Copyright © 2022 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.ijcard.2022.10.143
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1874-1754
EndPage 304
ExternalDocumentID 36306951
10_1016_j_ijcard_2022_10_143
S0167527322016552
Genre Comment
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ACDAQ
ACGFS
ACIEU
ACIUM
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
M29
M41
MO0
N9A
O-L
O9-
OA.
OAUVE
OL~
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SAE
SCC
SDF
SDG
SEL
SES
SPCBC
SSH
SSZ
T5K
UV1
Z5R
~G-
0SF
AACTN
AFCTW
AFKWA
AHHHB
AJOXV
AMFUW
.55
.GJ
29J
AAQXK
AAYWO
AAYXX
ABWVN
ABXDB
ACRPL
ADMUD
ADNMO
ADVLN
AFFNX
AGHFR
AGQPQ
AGRNS
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
FGOYB
G-2
HEB
HMK
HMO
HVGLF
HZ~
R2-
RIG
SEW
WUQ
X7M
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c345t-a4562ec2aa4b6d393f0d412560e106db1f8f3f9486de16100615e6a55163de3a3
IEDL.DBID .~1
ISSN 0167-5273
1874-1754
IngestDate Mon Jul 21 09:33:45 EDT 2025
Thu Apr 03 07:02:37 EDT 2025
Thu Apr 24 23:12:35 EDT 2025
Tue Jul 01 04:04:34 EDT 2025
Tue Dec 03 03:44:46 EST 2024
Tue Aug 26 16:54:35 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Aortic stenosis
VARC-3
Low-flow low-gradient
Normal-flow low-gradient
TAVI
Language English
License Copyright © 2022 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c345t-a4562ec2aa4b6d393f0d412560e106db1f8f3f9486de16100615e6a55163de3a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
PMID 36306951
PQID 2730316352
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_2730316352
pubmed_primary_36306951
crossref_citationtrail_10_1016_j_ijcard_2022_10_143
crossref_primary_10_1016_j_ijcard_2022_10_143
elsevier_sciencedirect_doi_10_1016_j_ijcard_2022_10_143
elsevier_clinicalkey_doi_10_1016_j_ijcard_2022_10_143
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-01-15
PublicationDateYYYYMMDD 2023-01-15
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-15
  day: 15
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle International journal of cardiology
PublicationTitleAlternate Int J Cardiol
PublicationYear 2023
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Salaun, Clavel, Hahn (bb0025) 2020
Chadha, Bohbot, Rusinaru, Marechaux, Tribouilloy (bb0075) 2019; 8
Vahanian, Beyersdorf, Praz (bb0005) 2022; 43
Berthelot-Richer, Pibarot, Capoulade (bb0085) 2016; 9
Namasivayam, He, Churchill (bb0095) 2020; 75
Mehrotra, Jansen, Flynn (bb0050) 2013; 34
Généreux, Piazza, Alu (bb0060) 2021; 42
Herrmann, Pibarot, Hueter (bb0100) 2013; 127
Clavel, Magne, Pibarot (bb0035) 2016; 37
Guzzetti, Pibarot, Clavel (bb0040) 2019; 20
Fischer-Rasokat, Renker, Liebetrau (bb0030) 2019; 12
Otto, Nishimura, Bonow (bb0010) 2021; 143
Steffen, Reissig, Andreae (bb0020) 2022
Clavel, Messika-Zeitoun, Pibarot (bb0080) 2013; 62
Baumgartner, Hung, Bermejo (bb0015) 2017; 18
Ozkan, Hachamovitch, Kapadia, Tuzcu, Marwick (bb0045) 2013; 128
Scrucca, Santucci, Aversa (bb0065) 2010; 45
Saeed, Vamvakidou, Seifert, Khattar, Li, Senior (bb0070) 2019; 20
Kadem, Dumesnil, Rieu, Durand, Garcia, Pibarot (bb0090) 2005; 91
Vahanian (10.1016/j.ijcard.2022.10.143_bb0005) 2022; 43
Baumgartner (10.1016/j.ijcard.2022.10.143_bb0015) 2017; 18
Namasivayam (10.1016/j.ijcard.2022.10.143_bb0095) 2020; 75
Steffen (10.1016/j.ijcard.2022.10.143_bb0020) 2022
Généreux (10.1016/j.ijcard.2022.10.143_bb0060) 2021; 42
Berthelot-Richer (10.1016/j.ijcard.2022.10.143_bb0085) 2016; 9
Fischer-Rasokat (10.1016/j.ijcard.2022.10.143_bb0030) 2019; 12
Otto (10.1016/j.ijcard.2022.10.143_bb0010) 2021; 143
Salaun (10.1016/j.ijcard.2022.10.143_bb0025) 2020
Herrmann (10.1016/j.ijcard.2022.10.143_bb0100) 2013; 127
Mehrotra (10.1016/j.ijcard.2022.10.143_bb0050) 2013; 34
Chadha (10.1016/j.ijcard.2022.10.143_bb0075) 2019; 8
Guzzetti (10.1016/j.ijcard.2022.10.143_bb0040) 2019; 20
Kadem (10.1016/j.ijcard.2022.10.143_bb0090) 2005; 91
Ozkan (10.1016/j.ijcard.2022.10.143_bb0045) 2013; 128
Clavel (10.1016/j.ijcard.2022.10.143_bb0080) 2013; 62
Clavel (10.1016/j.ijcard.2022.10.143_bb0035) 2016; 37
Saeed (10.1016/j.ijcard.2022.10.143_bb0070) 2019; 20
Scrucca (10.1016/j.ijcard.2022.10.143_bb0065) 2010; 45
27190103 - Eur Heart J. 2016 Sep 07;37(34):2645-57
References_xml – volume: 9
  start-page: 797
  year: 2016
  end-page: 805
  ident: bb0085
  article-title: Discordant grading of aortic stenosis severity
  publication-title: JACC Cardiovasc. Imaging
– start-page: 13
  year: 2020
  ident: bb0025
  article-title: Outcome of flow-gradient patterns of aortic stenosis after aortic valve replacement
  publication-title: Circulation
– volume: 127
  start-page: 2316
  year: 2013
  end-page: 2326
  ident: bb0100
  article-title: Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis
  publication-title: Circulation
– volume: 45
  start-page: 1388
  year: 2010
  end-page: 1395
  ident: bb0065
  article-title: Regression modeling of competing risk using R: an in depth guide for clinicians
  publication-title: Bone Marrow Transplant.
– volume: 128
  start-page: 622
  year: 2013
  end-page: 631
  ident: bb0045
  article-title: Impact of aortic valve replacement on outcome of symptomatic patients with severe aortic stenosis with low gradient and preserved left ventricular ejection fraction
  publication-title: Circulation
– volume: 20
  start-page: 1094
  year: 2019
  end-page: 1101
  ident: bb0070
  article-title: The impact of aortic valve replacement on survival in patients with normal flow low gradient severe aortic stenosis: a propensity-matched comparison
  publication-title: Eur. Heart J. Cardiovasc. Imaging
– volume: 12
  start-page: 752
  year: 2019
  end-page: 763
  ident: bb0030
  article-title: 1-year survival after TAVR of patients with low-flow, low-gradient and high-gradient aortic valve stenosis in matched study populations
  publication-title: JACC Cardiovasc. Interv.
– volume: 20
  start-page: 1102
  year: 2019
  end-page: 1104
  ident: bb0040
  article-title: Normal-flow low-gradient severe aortic stenosis is a frequent and real entity
  publication-title: Eur. Heart J. Cardiovasc. Imaging
– volume: 43
  start-page: 561
  year: 2022
  end-page: 632
  ident: bb0005
  article-title: 2021 ESC/EACTS guidelines for the management of valvular heart disease
  publication-title: Eur. Heart J.
– volume: 143
  start-page: e72
  year: 2021
  end-page: e227
  ident: bb0010
  article-title: 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines
  publication-title: Circulation
– volume: 8
  year: 2019
  ident: bb0075
  article-title: Outcome of normal-flow low-gradient severe aortic stenosis with preserved left ventricular ejection fraction: a propensity-matched study
  publication-title: J. Am. Heart Assoc.
– year: 2022
  ident: bb0020
  article-title: TAVI in patients with low-flow low-gradient aortic stenosis-short-term and long-term outcomes
  publication-title: Clin. Res. Cardiol.
– volume: 91
  start-page: 354
  year: 2005
  end-page: 361
  ident: bb0090
  article-title: Impact of systemic hypertension on the assessment of aortic stenosis
  publication-title: Heart
– volume: 34
  start-page: 1906
  year: 2013
  end-page: 1914
  ident: bb0050
  article-title: Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis
  publication-title: Eur. Heart J.
– volume: 42
  start-page: 1825
  year: 2021
  end-page: 1857
  ident: bb0060
  article-title: Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research
  publication-title: Eur. Heart J.
– volume: 18
  start-page: 254
  year: 2017
  end-page: 275
  ident: bb0015
  article-title: Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
  publication-title: Eur. Heart J. Cardiovasc. Imaging
– volume: 75
  start-page: 1758
  year: 2020
  end-page: 1769
  ident: bb0095
  article-title: Transvalvular flow rate determines prognostic value of aortic valve area in aortic stenosis
  publication-title: J. Am. Coll. Cardiol.
– volume: 37
  start-page: 2645
  year: 2016
  end-page: 2657
  ident: bb0035
  article-title: Low-gradient aortic stenosis
  publication-title: Eur. Heart J.
– volume: 62
  start-page: 2329
  year: 2013
  end-page: 2338
  ident: bb0080
  article-title: The complex nature of discordant severe calcified aortic valve disease grading
  publication-title: J. Am. Coll. Cardiol.
– volume: 20
  start-page: 1094
  year: 2019
  ident: 10.1016/j.ijcard.2022.10.143_bb0070
  article-title: The impact of aortic valve replacement on survival in patients with normal flow low gradient severe aortic stenosis: a propensity-matched comparison
  publication-title: Eur. Heart J. Cardiovasc. Imaging
  doi: 10.1093/ehjci/jez191
– volume: 45
  start-page: 1388
  year: 2010
  ident: 10.1016/j.ijcard.2022.10.143_bb0065
  article-title: Regression modeling of competing risk using R: an in depth guide for clinicians
  publication-title: Bone Marrow Transplant.
  doi: 10.1038/bmt.2009.359
– volume: 37
  start-page: 2645
  year: 2016
  ident: 10.1016/j.ijcard.2022.10.143_bb0035
  article-title: Low-gradient aortic stenosis
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehw096
– start-page: 13
  year: 2020
  ident: 10.1016/j.ijcard.2022.10.143_bb0025
  article-title: Outcome of flow-gradient patterns of aortic stenosis after aortic valve replacement
  publication-title: Circulation
– volume: 62
  start-page: 2329
  year: 2013
  ident: 10.1016/j.ijcard.2022.10.143_bb0080
  article-title: The complex nature of discordant severe calcified aortic valve disease grading
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2013.08.1621
– volume: 34
  start-page: 1906
  year: 2013
  ident: 10.1016/j.ijcard.2022.10.143_bb0050
  article-title: Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/eht094
– volume: 12
  start-page: 752
  year: 2019
  ident: 10.1016/j.ijcard.2022.10.143_bb0030
  article-title: 1-year survival after TAVR of patients with low-flow, low-gradient and high-gradient aortic valve stenosis in matched study populations
  publication-title: JACC Cardiovasc. Interv.
  doi: 10.1016/j.jcin.2019.01.233
– volume: 128
  start-page: 622
  year: 2013
  ident: 10.1016/j.ijcard.2022.10.143_bb0045
  article-title: Impact of aortic valve replacement on outcome of symptomatic patients with severe aortic stenosis with low gradient and preserved left ventricular ejection fraction
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.112.001094
– year: 2022
  ident: 10.1016/j.ijcard.2022.10.143_bb0020
  article-title: TAVI in patients with low-flow low-gradient aortic stenosis-short-term and long-term outcomes
  publication-title: Clin. Res. Cardiol.
  doi: 10.1007/s00392-022-02011-4
– volume: 42
  start-page: 1825
  year: 2021
  ident: 10.1016/j.ijcard.2022.10.143_bb0060
  article-title: Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehaa799
– volume: 43
  start-page: 561
  year: 2022
  ident: 10.1016/j.ijcard.2022.10.143_bb0005
  article-title: 2021 ESC/EACTS guidelines for the management of valvular heart disease
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehab395
– volume: 18
  start-page: 254
  year: 2017
  ident: 10.1016/j.ijcard.2022.10.143_bb0015
  article-title: Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
  publication-title: Eur. Heart J. Cardiovasc. Imaging
  doi: 10.1093/ehjci/jew335
– volume: 9
  start-page: 797
  year: 2016
  ident: 10.1016/j.ijcard.2022.10.143_bb0085
  article-title: Discordant grading of aortic stenosis severity
  publication-title: JACC Cardiovasc. Imaging
  doi: 10.1016/j.jcmg.2015.09.026
– volume: 143
  start-page: e72
  year: 2021
  ident: 10.1016/j.ijcard.2022.10.143_bb0010
  article-title: 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines
  publication-title: Circulation
– volume: 8
  year: 2019
  ident: 10.1016/j.ijcard.2022.10.143_bb0075
  article-title: Outcome of normal-flow low-gradient severe aortic stenosis with preserved left ventricular ejection fraction: a propensity-matched study
  publication-title: J. Am. Heart Assoc.
  doi: 10.1161/JAHA.119.012301
– volume: 75
  start-page: 1758
  year: 2020
  ident: 10.1016/j.ijcard.2022.10.143_bb0095
  article-title: Transvalvular flow rate determines prognostic value of aortic valve area in aortic stenosis
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2020.02.046
– volume: 20
  start-page: 1102
  year: 2019
  ident: 10.1016/j.ijcard.2022.10.143_bb0040
  article-title: Normal-flow low-gradient severe aortic stenosis is a frequent and real entity
  publication-title: Eur. Heart J. Cardiovasc. Imaging
  doi: 10.1093/ehjci/jez211
– volume: 91
  start-page: 354
  year: 2005
  ident: 10.1016/j.ijcard.2022.10.143_bb0090
  article-title: Impact of systemic hypertension on the assessment of aortic stenosis
  publication-title: Heart
  doi: 10.1136/hrt.2003.030601
– volume: 127
  start-page: 2316
  year: 2013
  ident: 10.1016/j.ijcard.2022.10.143_bb0100
  article-title: Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.112.001290
– reference: 27190103 - Eur Heart J. 2016 Sep 07;37(34):2645-57
SSID ssj0004998
Score 2.3968887
Snippet Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to...
Normal-flow (stroke volume index, SVi >35 ml/m ) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to...
Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 299
SubjectTerms Aortic stenosis
Aortic Valve - surgery
Aortic Valve Stenosis - diagnostic imaging
Aortic Valve Stenosis - surgery
Humans
Low-flow low-gradient
Normal-flow low-gradient
Severity of Illness Index
Stroke Volume
TAVI
Transcatheter Aortic Valve Replacement - adverse effects
Treatment Outcome
VARC-3
Ventricular Function, Left
Title TAVI for patients with normal-flow low-gradient compared to high-gradient aortic stenosis
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0167527322016552
https://dx.doi.org/10.1016/j.ijcard.2022.10.143
https://www.ncbi.nlm.nih.gov/pubmed/36306951
https://www.proquest.com/docview/2730316352
Volume 371
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDI4mkBAXxJvxmILEtXskadceJ8Q0QNuFDY1TlTQJGppaRIu48dux22aIwwTi0IsbK63jOJ8T2yHkSsueimwEM41JBQ5Kv-tJK7XHrApFCGuCNpjgPJ4Eo5m4m_vzBrl2uTAYVlnb_sqml9a6pnRqaXZeF4vOAwbQY_kwxjAlx0c7LEQftbz9-R3mAYg-dPW9sbVLnytjvBYvCYwDeImMtZEq-LrlaR38LJeh4S7ZqfEjHVSfuEcaJt0nW-P6hPyAPE0Hj7cUkCitK6bmFLdaaYrYdOnZZfZB4fGe38pYr4K6IHRaZBRrF3-_kRl2QkEN0ixf5IdkNryZXo-8-voEL-HCLzyJzo1JmJRCBZpH3Ha16CHEMeAHatWzoeU2EmGgDeC-EtyYQOLJGdeGS35ENtIsNSeEIkgxhikVBUxYziMAYV0lVMi0r1WQNAl3UouTurY4XnGxjF0Q2UtcyTpGWZdUwZvEW3G9VrU1fmnvuwGJXd4oWLoYjP8vfP0V3w_d-gPnpRv3GKYdnqXI1GTveQyaBOYQ0BprkuNKIVb_wAPwwwC5nv673zOyjdfa41ZPzz8nG8Xbu7kA8FOoVqndLbI5uL0fTb4AuCACxw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB6hVtrlstoXbFkWvNJeQ1vbSZNjhUAt0F62IDhZdmyviqoE0aD9-8wkThEHBOKQi5OR4_F4_I09D4A_Vg9N5jNcaVwbNFBGg0h7bSPuTSpT3BOsowDn2TyZXMqz6_h6C47bWBhyqwy6v9HptbYOLf3Azf7dctn_Sw70lD6McwrJiVEPdyk7VdyB7nh6Ppk_hUdmdUncOsU3EbQRdLWb1_I2x6lAQ5HzI2qV4qUd6iUEWu9Ep5_hU4CQbNz85RfYcsVX-DALl-Tf4GYxvpoyBKMsJE1dMzptZQXB01XkV-V_hk_0775296pY64fOqpJR-uKnN7qkThhKQlGul-vvcHl6sjieRKGCQpQLGVeRJvvG5VxraRIrMuEHVg4J5Tg0Ba0Z-tQLn8k0sQ6hX41vXKLp8kxYJ7TYgU5RFu4HMMIpznFjsoRLL0SGOGxgpEm5ja1J8h6IlmsqD-nFqcrFSrV-ZLeq4bUiXtetUvQg2lDdNek1Xvk-bidEtaGjqOwU6v9X6EYbumfi9QbK3-28K1x5dJ2iC1c-rBVKEmpEBGy8B7uNQGzGIBI0xRC87r2730P4OFnMLtTFdH7-E7apyj2d_AzjfehU9w_uF2KhyhwEWX8Ek3sFeA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TAVI+for+patients+with+normal-flow+low-gradient+compared+to+high-gradient+aortic+stenosis&rft.jtitle=International+journal+of+cardiology&rft.au=Steffen%2C+Julius&rft.au=Andreae%2C+David&rft.au=Nabauer%2C+Michael&rft.au=Rei%C3%9Fig%2C+Nikolas&rft.date=2023-01-15&rft.issn=0167-5273&rft.volume=371&rft.spage=299&rft.epage=304&rft_id=info:doi/10.1016%2Fj.ijcard.2022.10.143&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ijcard_2022_10_143
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-5273&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-5273&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-5273&client=summon